Sterling Investment Management LLC Acquires 15,349 Shares of Danaher Corporation $DHR

Sterling Investment Management LLC increased its holdings in Danaher Corporation (NYSE:DHR) by 379.1% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 19,398 shares of the conglomerate’s stock after purchasing an additional 15,349 shares during the quarter. Danaher accounts for about 2.0% of Sterling Investment Management LLC’s holdings, making the stock its 16th largest holding. Sterling Investment Management LLC’s holdings in Danaher were worth $4,298,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of DHR. Veery Capital LLC grew its holdings in Danaher by 3.1% in the third quarter. Veery Capital LLC now owns 1,581 shares of the conglomerate’s stock valued at $350,000 after purchasing an additional 48 shares during the period. Studio Investment Management LLC raised its stake in shares of Danaher by 3.3% during the 2nd quarter. Studio Investment Management LLC now owns 1,581 shares of the conglomerate’s stock worth $302,000 after buying an additional 51 shares during the period. JDH Wealth Management LLC raised its stake in shares of Danaher by 4.5% during the 1st quarter. JDH Wealth Management LLC now owns 1,264 shares of the conglomerate’s stock worth $240,000 after buying an additional 55 shares during the period. OLD Second National Bank of Aurora raised its stake in shares of Danaher by 0.5% during the 1st quarter. OLD Second National Bank of Aurora now owns 12,114 shares of the conglomerate’s stock worth $2,297,000 after buying an additional 57 shares during the period. Finally, Adelphi Trust Co lifted its position in shares of Danaher by 2.5% during the 3rd quarter. Adelphi Trust Co now owns 2,365 shares of the conglomerate’s stock valued at $524,000 after buying an additional 57 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Price Performance

NYSE:DHR opened at $228.87 on Friday. The stock has a 50 day moving average of $214.04 and a two-hundred day moving average of $195.97. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The firm has a market cap of $160.89 billion, a P/E ratio of 40.65, a price-to-earnings-growth ratio of 2.88 and a beta of 0.76. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48.

Danaher (NYSE:DHR) last released its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating the consensus estimate of $1.85 by $0.09. The business had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%. The business’s quarterly revenue was up 5.5% compared to the same quarter last year. During the same quarter last year, the business posted $0.77 earnings per share. On average, analysts expect that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be paid a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 30th. Danaher’s dividend payout ratio is currently 28.42%.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on the stock. The Goldman Sachs Group lifted their price target on shares of Danaher from $210.00 to $250.00 and gave the company a “buy” rating in a research note on Monday, September 21st. Weiss Ratings upgraded shares of Danaher from a “hold (c-)” rating to a “hold (c)” rating in a research report on Wednesday, September 16th. Royal Bank Of Canada increased their price objective on shares of Danaher from $215.00 to $250.00 and gave the company an “outperform” rating in a report on Monday, October 5th. Wall Street Zen downgraded shares of Danaher from a “buy” rating to a “hold” rating in a report on Sunday. Finally, Wells Fargo & Company dropped their target price on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a research report on Wednesday, July 22nd. Two investment analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $235.41.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.

The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.